Life Sciences

FDA releases updated draft guidance for ANA test systems

Device Regulation Alert: Safety, Compliance and Reimbursement News, February 9, 2009

New developments for in vitro diagnostic devices prompted the FDA to release a revised guidance document, “Recommendations for Anti-Nuclear Antibody (ANA) Test System Premarket (510(k)) Submissions.”

This revised guidance applies only to in vitro diagnostic devices that detect anti-nuclear antibodies as an aid in the diagnosis of autoimmune disease, not tests that differentially diagnose autoimmune diseases.

Comments

0 comments on “FDA releases updated draft guidance for ANA test systems

 

Most Popular